In patients with coronary artery disease (CAD), the novel DynamX Bioadaptor restores arterial hemodynamic modulation, shows significant clinical benefits and has superior outcomes compared with the commercially available Resolute Onyx stent, 2-year results from BIOADAPTOR RCT study show.